Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/1857
Full metadata record
DC FieldValueLanguage
dc.contributorBoolell, V.en_US
dc.date.accessioned2022-01-27T04:23:13Z-
dc.date.available2022-01-27T04:23:13Z-
dc.date.issued2021-
dc.identifier.govdoc01852en_US
dc.identifier.urihttp://hdl.handle.net/11054/1857-
dc.description.provenanceSubmitted by Gemma Siemensma (gemmas@bhs.org.au) on 2022-01-13T02:28:17Z No. of bitstreams: 0en
dc.description.provenanceApproved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2022-01-27T04:23:13Z (GMT) No. of bitstreams: 0en
dc.description.provenanceMade available in DSpace on 2022-01-27T04:23:13Z (GMT). No. of bitstreams: 0 Previous issue date: 2021en
dc.titleImmunotherapy for metastatic cancer.en_US
dc.typeConferenceen_US
dc.type.specifiedPresentationen_US
dc.bibliographicCitation.conferencedateMay 13 -14en_US
dc.bibliographicCitation.conferencenameWhere the wild things are - At the fringes of palliative care.en_US
dc.bibliographicCitation.conferenceplaceOnlineen_US
dc.subject.healththesaurusIMMUNOTHERAPYen_US
dc.subject.healththesaurusMETASTATIC CANCERen_US
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.